A detailed history of Tiaa, Fsb transactions in Abb Vie Inc. stock. As of the latest transaction made, Tiaa, Fsb holds 232,061 shares of ABBV stock, worth $45.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
232,061
Previous 234,186 0.91%
Holding current value
$45.2 Million
Previous $37.3 Million 16.23%
% of portfolio
0.11%
Previous 0.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $281,583 - $350,412
-2,125 Reduced 0.91%
232,061 $31.3 Million
Q1 2023

Apr 19, 2023

SELL
$144.61 - $166.54 $6.06 Million - $6.98 Million
-41,922 Reduced 15.18%
234,186 $37.3 Million
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $1.84 Million - $2.21 Million
-13,295 Reduced 4.59%
276,108 $44.6 Million
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $7.07 Million - $8.11 Million
-52,696 Reduced 15.4%
289,403 $38.8 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $2.02 Million - $2.57 Million
-14,699 Reduced 4.12%
342,099 $52.4 Million
Q1 2022

Apr 13, 2022

SELL
$131.98 - $163.75 $7.98 Million - $9.9 Million
-60,438 Reduced 14.49%
356,798 $57.7 Million
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $170,169 - $215,313
-1,584 Reduced 0.38%
417,236 $56.3 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $419,216 - $475,873
3,940 Added 0.95%
418,820 $45.2 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $217,574 - $242,390
2,068 Added 0.5%
414,880 $46.7 Million
Q1 2021

Apr 21, 2021

SELL
$102.3 - $112.62 $4.48 Million - $4.93 Million
-43,781 Reduced 9.59%
412,812 $44.7 Million
Q4 2020

Jan 21, 2021

SELL
$80.49 - $108.67 $74,775 - $100,954
-929 Reduced 0.2%
456,593 $48.9 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $4.25 Million - $4.99 Million
49,482 Added 12.13%
457,522 $40.1 Million
Q2 2020

Jul 15, 2020

BUY
$73.37 - $98.18 $1.87 Million - $2.5 Million
25,486 Added 6.66%
408,040 $40.1 Million
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $1.63 Million - $2.47 Million
25,299 Added 7.08%
382,554 $29.1 Million
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $2.16 Million - $2.7 Million
-29,964 Reduced 7.74%
357,255 $31.6 Million
Q3 2019

Oct 08, 2019

BUY
$62.98 - $75.72 $13.7 Million - $16.5 Million
218,230 Added 129.14%
387,219 $29.3 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $191,449 - $244,717
-2,914 Reduced 1.7%
168,989 $12.3 Million
Q1 2019

Apr 15, 2019

BUY
$77.14 - $90.79 $27,847 - $32,775
361 Added 0.21%
171,903 $13.9 Million
Q4 2018

Apr 15, 2019

BUY
$77.85 - $96.01 $13.4 Million - $16.5 Million
171,542 New
171,542 $15.8 Million
Q4 2018

Feb 22, 2019

SELL
$77.85 - $96.01 $13.5 Million - $16.7 Million
-173,728 Closed
0 $0
Q3 2018

Oct 18, 2018

SELL
$88.91 - $98.84 $1.08 Million - $1.2 Million
-12,156 Reduced 6.54%
173,728 $16.4 Million
Q2 2018

Jul 20, 2018

SELL
$89.78 - $106.23 $5.14 Million - $6.08 Million
-57,278 Reduced 23.56%
185,884 $17.2 Million
Q1 2018

Apr 18, 2018

SELL
$92.01 - $123.21 $6.83 Million - $9.14 Million
-74,189 Reduced 23.38%
243,162 $23 Million
Q4 2017

Jan 29, 2018

BUY
$89.56 - $98.21 $1.06 Million - $1.16 Million
11,851 Added 3.88%
317,351 $30.7 Million
Q3 2017

Oct 24, 2017

BUY
$69.85 - $89.22 $21.3 Million - $27.3 Million
305,500
305,500 $27.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tiaa, Fsb Portfolio

Follow Tiaa, Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.